Morgan Stanley’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.8M Sell
1,051,997
-65,980
-6% -$1.71M ﹤0.01% 2382
2025
Q4
$22.2M Buy
1,117,977
+329,750
+42% +$6.34M ﹤0.01% 2842
2025
Q3
$14.4M Buy
788,227
+276,584
+54% +$4.55M ﹤0.01% 3210
2025
Q2
$8.06M Sell
511,643
-291,202
-36% -$3.7M ﹤0.01% 3637
2025
Q1
$10.2M Sell
802,845
-736,040
-48% -$11.6M ﹤0.01% 3327
2024
Q4
$33.9M Buy
1,538,885
+1,287,065
+511% +$27.1M ﹤0.01% 2220
2024
Q3
$4.49M Sell
251,820
-194,326
-44% -$3.11M ﹤0.01% 4042
2024
Q2
$7.16M Buy
446,146
+93,218
+26% +$1.47M ﹤0.01% 3596
2024
Q1
$5.24M Buy
352,928
+9,402
+3% +$150K ﹤0.01% 3882
2023
Q4
$6.14M Buy
343,526
+128,460
+60% +$2.08M ﹤0.01% 4257
2023
Q3
$4.11M Sell
215,066
-188,636
-47% -$3.27M ﹤0.01% 3893
2023
Q2
$6.4M Sell
403,702
-136,724
-25% -$2.25M ﹤0.01% 3573
2023
Q1
$9.39M Sell
540,426
-347,175
-39% -$6.17M ﹤0.01% 3207
2022
Q4
$15M Buy
887,601
+347,639
+64% +$5.61M ﹤0.01% 2639
2022
Q3
$6.92M Buy
539,962
+310,947
+136% +$4.46M ﹤0.01% 3358
2022
Q2
$2.38M Buy
229,015
+100,667
+78% +$1.34M ﹤0.01% 4396
2022
Q1
$1.75M Sell
128,348
-249,517
-66% -$3.67M ﹤0.01% 4615
2021
Q4
$4.99M Buy
377,865
+302,751
+403% +$3.81M ﹤0.01% 3723
2021
Q3
$594K Sell
75,114
-91,188
-55% -$628K ﹤0.01% 5382
2021
Q2
$1.14M Sell
166,302
-74,045
-31% -$457K ﹤0.01% 5002
2021
Q1
$1.47M Buy
240,347
+16,586
+7% +$69.3K ﹤0.01% 4489
2020
Q4
$700K Buy
223,761
+135,909
+155% +$474K ﹤0.01% 4868
2020
Q3
$224K Sell
87,852
-88,477
-50% -$227K ﹤0.01% 5051
2020
Q2
$402K Sell
176,329
-390,107
-69% -$834K ﹤0.01% 4708
2020
Q1
$595K Sell
566,436
-267,283
-32% -$903K ﹤0.01% 4276
2019
Q4
$3.04M Buy
833,719
+329,829
+65% +$1.14M ﹤0.01% 3697
2019
Q3
$1.83M Sell
503,890
-1,150
-0.2% -$4.92K ﹤0.01% 3874
2019
Q2
$2.12M Buy
505,040
+198,835
+65% +$795K ﹤0.01% 3732
2019
Q1
$1.09M Buy
306,205
+71,043
+30% +$236K ﹤0.01% 4047
2018
Q4
$520K Sell
235,162
-758,551
-76% -$3.13M ﹤0.01% 4755
2018
Q3
$6.36M Sell
993,713
-224,407
-18% -$1.59M ﹤0.01% 2928
2018
Q2
$9.07M Sell
1,218,120
-108,137
-8% -$813K ﹤0.01% 2482
2018
Q1
$9.35M Sell
1,326,257
-213,545
-14% -$1.58M ﹤0.01% 2403
2017
Q4
$11.9M Sell
1,539,802
-377,535
-20% -$3.15M ﹤0.01% 2225
2017
Q3
$16M Buy
1,917,337
+1,070,542
+126% +$6.67M ﹤0.01% 1787
2017
Q2
$3.6M Buy
846,795
+142,357
+20% +$571K ﹤0.01% 3228
2017
Q1
$2.68M Buy
704,438
+83,995
+14% +$333K ﹤0.01% 3543
2016
Q4
$2.48M Buy
620,443
+285,760
+85% +$1.17M ﹤0.01% 3739
2016
Q3
$1.51M Buy
334,683
+710
+0.2% +$3.65K ﹤0.01% 3733
2016
Q2
$1.64M Sell
333,973
-141,655
-30% -$803K ﹤0.01% 3586
2016
Q1
$5.59M Sell
475,628
-384,882
-45% -$5.35M ﹤0.01% 2421
2015
Q4
$17.1M Buy
860,510
+293,839
+52% +$7.26M 0.01% 1525
2015
Q3
$13.8M Sell
566,671
-47,520
-8% -$1.23M 0.01% 1682
2015
Q2
$15.6M Buy
614,191
+25,071
+4% +$665K 0.01% 1703
2015
Q1
$14.2M Buy
589,120
+213,884
+57% +$5.41M 0.01% 1739
2014
Q4
$8.41M Buy
375,236
+4,772
+1% +$124K ﹤0.01% 2227
2014
Q3
$10.2M Sell
370,464
-16,373
-4% -$495K ﹤0.01% 1997
2014
Q2
$12.3M Sell
386,837
-708,711
-65% -$21.1M ﹤0.01% 1840
2014
Q1
$28.3M Sell
1,095,548
-1,712,751
-61% -$46.7M 0.01% 1099
2013
Q4
$73.1M Buy
2,808,299
+3,236
+0.1% +$90.4K 0.03% 567
2013
Q3
$76.5M Sell
2,805,063
-149,491
-5% -$4.7M 0.04% 499
2013
Q2
$107M Buy
+2,954,554
New +$106M 0.05% 381

Other funds holding CLMT

Morgan Stanley's CLMT Position: Q1 2026 in Review

Morgan Stanley reduced its Calumet Specialty Products (CLMT) stake by 5.9% in Q1 2026, selling an estimated $1.71M and leaving 1,051,997 shares worth $37.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Morgan Stanley first reported a position in CLMT in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q2 2013. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Morgan Stanley held 1,051,997 shares of Calumet Specialty Products worth $37.8M as of Q1 2026.
  • Morgan Stanley sold 65,980 Calumet Specialty Products shares in Q1 2026, an estimated $1.71M.
  • Calumet Specialty Products made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2382 holding.
  • Morgan Stanley first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Calumet Specialty Products position peaked at $107M in Q2 2013.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.